Immediate Impact
4 from Science/Nature 57 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Aptamer-Based Detection of Circulating Targets for Precision Medicine
2021 Standout
Works of Claus-Peter Schneider being referenced
Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer: Safety of Avastin in Lung trial (MO19390)
2011
Standardized quantification of circulating peripheral tumor cells from lung and breast cancer
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Claus-Peter Schneider | 310 | 377 | 130 | 18 | 582 | |
| R. Molife | 276 | 290 | 299 | 24 | 688 | |
| Christina Arce | 274 | 224 | 144 | 18 | 556 | |
| Tahsin M. Khan | 355 | 333 | 268 | 19 | 573 | |
| Tianli Zhang | 263 | 284 | 219 | 24 | 603 | |
| Daniela Morales-Espinosa | 185 | 274 | 203 | 25 | 521 | |
| Angel Qin | 190 | 325 | 169 | 32 | 528 | |
| Maria Rosa Cappelletti | 244 | 305 | 205 | 32 | 616 | |
| Theodore S. Nowicki | 107 | 387 | 163 | 29 | 601 | |
| Ruslan D. Novosiadly | 109 | 337 | 197 | 20 | 516 | |
| Raphael Brandão Moreira | 349 | 472 | 103 | 26 | 678 |
All Works
Loading papers...